Relationships between expression of apolipoprotein e and β-amyloid precursor protein are altered in proximity to Alzheimer β-amyloid plaques: Potential explanations from cell culture studies

Journal of Neuropathology and Experimental Neurology

Volumn 67, Issue 8, 2008, Pages 773-783

  Barger, Steven W ^a,c   Dewall, Kevin Mark ^a   Liu, Ling ^a   Mrak, Robert E ^a,b,d   Griffin, W Sue T ^a,b,c  

^a Department of Geriatrics ^*

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Alzheimer; Amyloid A peptide; Apolipoprotein E; Glutamate; Immunofluorescence; RNA interference

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; GLUTAMIC ACID; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; SMALL INTERFERING RNA;

ADULT; AGED; AGING; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ANIMAL CELL; ANTIGENICITY; ARTICLE; BRAIN NERVE CELL; CELL STRESS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IN VIVO STUDY; MALE; MOUSE; NERVE CELL CULTURE; NEURITE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SENILE PLAQUE; WESTERN BLOTTING; AGE; ANIMAL; BRAIN; CELL CULTURE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; NEOCORTEX; NERVE CELL; NEWBORN; PATHOLOGY; PHYSIOLOGY; RAT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANIMALS, NEWBORN; APOLIPOPROTEINS E; BRAIN; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION; GLUTAMIC ACID; HUMANS; MALE; MIDDLE AGED; NEOCORTEX; NEURONS; RATS; RNA, SMALL INTERFERING; SENILE PLAQUES;

EID: 52249090247     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e318180ec47     Document Type: Article

References (68)

1. Rosen DR, Martin-Morris L, Luo LQ, et al. A Drosophila gene encoding a protein resembling the human A-amyloid protein precursor. Proc Natl Acad Sci U S A 1989;86:2478-82
2. Dawson GR, Seabrook GR, Zheng H, et al. Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein. Neuroscience 1999;90:1-13
3. Masliah E, Westland CE, Rockenstein EM, et al. Amyloid precursor proteins protect neurons of transgenic mice against acute and chronic excitotoxic injuries in vivo. Neuroscience 1997;78:135-46
4. Prasher VP, Farrer MJ, Kessling AM, et al. Molecular mapping of Alzheimer-type dementia in Down's syndrome. Ann Neurol 1998;43: 380-83
5. Griffin WS, Sheng JG, McKenzie JE, et al. Life-long overexpression of S100beta in Down's syndrome: Implications for Alzheimer pathogenesis. Neurobiol Aging 1998;19:401-5
6. Rovelet-Lecrux A, Hannequin D, Raux G, et al. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 2006;38:24-26
7. Sleegers K, Brouwers N, Gijselinck I, et al. APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy. Brain 2006;129:2977-83
8. Moir RD, Lynch T, Bush AI, et al. Relative increase in Alzheimer's disease of soluble forms of cerebral Abeta amyloid protein precursor containing the Kunitz protease inhibitory domain. J Biol Chem 1998; 273:5013-19
9. Panegyres PK, Zafiris-Toufexis K, Kakulas BA. Amyloid precursor protein gene isoforms in Alzheimer disease and other neurodegenerative disorders. J Neurol Sci 2000;173:81-92
10. Harrison PJ, Barton AJ, Procter AW, et al. The effects of Alzheimer's disease, other dementias, and premortem course on beta-amyloid precursor protein messenger RNA in frontal cortex. J Neurochem 1994;62: 635-44
11. Choi BH, Kim RC, Vaughan PJ, et al. Decreases in protease nexins in Alzheimer's disease brain. Neurobiol Aging 1995;16:557-62
12. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-23
13. Namba Y, Tomonaga M, Kawasaki H, et al. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt- Jakob disease. Brain Res 1991;541:163-66
14. Nicoll JR, Roberts GW, Graham DI. Apolipoprotein E ?4 allele is associated with deposition of amyloid A-protein following head injury. Nat Med 1995;1:135-37
15. Sheng JG, Mrak RE, Griffin WS. Apolipoprotein E distribution among different plaque types in Alzheimer's disease: Implications for its role in plaque progression. Neuropathol Appl Neurobiol 1996;22:334-41
16. Bales KR, Verina T, Cummins DJ, et al. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 96;1999:15233-38
17. Wisniewski T, Castano EM, Golabek A, et al. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am J Pathol 1994;145:1030-35
18. Nathan BP, Bellosta S, Sanan DA, et al. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 1994; 264:850-52
19. Strittmatter WJ, Saunders AM, Goedert M, et al. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: Implications for Alzheimer disease. Proc Natl Acad Sci U S A 1994; 91:11183-86
20. Tesseur I, Van Dorpe J, Spittaels K, et al. Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice. Am J Pathol 2000;156:951-64
21. Huang Y, Liu XQ, Wyss-Coray T, et al. Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangleYlike intracellular inclusions in neurons. Proc Natl Acad Sci U S A 2001;98: 8838-43
22. Harris FM, Brecht WJ, Xu Q, et al. Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's diseaseYlike neurodegeneration and behavioral deficits in transgenic mice. Proc Natl Acad Sci U S A 2003; 100:10966-71
23. White F, Nicoll JA, Horsburgh K. Alterations in ApoE and ApoJ in relation to degeneration and regeneration in a mouse model of entorhinal cortex lesion. Exp Neurol 2001;169:307-18
24. Kay AD, Petzold A, Kerr M, et al. Cerebrospinal fluid apolipoprotein E concentration decreases after traumatic brain injury. J Neurotrauma 2003;20:243-50 (Pubitemid 36373821)
25. Wenham PR, Price WH, Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991;337:1158-59
26. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Aging NIo, disease tRIWGoDCftNAoAs. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 1997;18:S1-S2
27. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41:479-86
28. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathologica 1991;82:239-59
29. Liu L, Li Y, Van Eldik LJ, et al. S100B-induced microglial and neuronal IL-1 expression is mediated by cell type-specific transcription factors. J Neurochem 2005;92:546-53
30. Li Y, Liu L, Barger SW, et al. Vitamin E suppression of microglial activation is neuroprotective. J Neurosci Res 2001;66:163-70
31. Libus J, Storchova H. Quantification of cDNA generated by reverse transcription of total RNA provides a simple alternative tool for quantitative RT-PCR normalization. Biotechniques 2006;41:156, 158, 160 passim
32. Li Y, Wang J, Sheng JG, et al. S100A increases levels of A-amyloid precursor protein and its encoding mRNA in rat neuronal cultures. J Neurochem 1998;71:1421-28
33. Barger SW. An unconventional hypothesis of oxidation in Alzheimer's disease: Intersections with excitotoxicity. Front Biosci 2004;9:3286-95
34. Barger SW, Goodwin ME, Porter MM, et al. Glutamate release from activated microglia requires the oxidative burst and lipid peroxidation. J Neurochem 2007;101:1205-13
35. Griffin WS, Sheng JG, Roberts GW, et al. Interleukin-1 expression in different plaque types in Alzheimer's disease: Significance in plaque evolution. J Neuropathol Exp Neurol 1995;54:276-81
36. Kimura N, Tanemura K, Nakamura S, et al. Age-related changes of Alzheimer's diseaseYassociated proteins in cynomolgus monkey brains. Biochem Biophys Res Commun 2003;310:303-11
37. Perez RG, Zheng H, Van der Ploeg LH, et al. The A-amyloid precursor protein of Alzheimer's disease enhances neuron viability and modulates neuronal polarity. J Neurosci 1997;17:9407-14.
38. Moechars D, Lorent K, De Strooper B, et al. Expression in brain of amyloid precursor protein mutated in the alpha-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice. EMBO J 1996;15:1265-74
39. Smith-Swintosky VL, Pettigrew LC, Craddock SD, et al. Secreted forms of amyloid precursor protein protect against transient cerebral ischemia in rats. J Neurochem 1994;63:781-84
40. Thornton E, Vink R, Blumbergs PC, et al. Soluble amyloid precursor protein alpha reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats. Brain Res 2006;1094: 38-46
41. Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 1997;18:351-57
42. Lindner MD, Hogan JB, Krause RG, et al. Soluble Abeta and cognitive function in aged F-344 rats and Tg2576 mice. Behav Brain Res 2006; 173:62-75
43. Barger SW, Basile AS. Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function. J Neurochem 2001;76:846-54
44. Ikezu T, Luo X, Weber GA, et al. Amyloid precursor proteinYprocessing products affect mononuclear phagocyte activation: Pathways for sAPPand Abeta-mediated neurotoxicity. J Neurochem 2003;85:925-34
45. Bell KF, de Kort GJ, Steggerda S, et al. Structural involvement of the glutamatergic presynaptic boutons in a transgenic mouse model expressing early onset amyloid pathology. Neurosci Lett 2003;353:143-47
46. Bell KF, Bennett DA, Cuello AC. Paradoxical upregulation of glutamatergic presynaptic boutons during mild cognitive impairment. J Neurosci 2007;27:10810-17
47. Bell KF, Ducatenzeiler A, Ribeiro-da-Silva A, et al. The amyloid pathology progresses in a neurotransmitter-specific manner. Neurobiol Aging 2006;27:1644-57
48. Qin S, Colin C, Hinners I, et al. System Xc- and apolipoprotein E expressed by microglia have opposite effects on the neurotoxicity of amyloid-beta peptide 1-40. J Neurosci 2006;26:3345-56
49. Roses AD, Gilbert J, Xu PT, et al. Cis-acting human ApoE tissue expression element is associated with human pattern of intraneuronal ApoE in transgenic mice. Neurobiol Aging 1998;19:S53-58
50. Chang DJ, Paik YK, Leren TP, et al. Characterization of a human apolipoprotein E gene enhancer element and its associated protein factors. J Biol Chem 1990;265:9496-504
51. Mao X, Yang SH, Simpkins JW, et al. Glutamate receptor activation evokes calpain-mediated degradation of Sp3 and Sp4, the prominent Sp-family transcription factors in neurons. J Neurochem 2007;100: 1300-14
52. Mao X, Moerman-Herzog AM, Wang W, et al. Differential transcriptional control of the superoxide dismutase-2 JB element in neurons and astrocytes. J Biol Chem 2006;281:35863-72
53. Fazio S, Yao Z. The enhanced association of apolipoprotein E with apolipoprotein BYcontaining lipoproteins in serum-stimulated hepatocytes occurs intracellularly. Arterioscler Thromb Vasc Biol 1995;15:593-600
54. Wang S, McLeod RS, Gordon DA, et al. The microsomal triglyceride transfer protein facilitates assembly and secretion of apolipoprotein BYcontaining lipoproteins and decreases cotranslational degradation of apolipoprotein B in transfected COS-7 cells. J Biol Chem 1996;271: 14124-33
55. LaDu MJ, Gilligan SM, Lukens JR, et al. Nascent astrocyte particles differ from lipoproteins in CSF. J Neurochem 1998;70:2070-81
56. Legleiter J, DeMattos RB, Holtzman DM, et al. In situ AFM studies of astrocyte-secreted apolipoprotein E- and J-containing lipoproteins. J Colloid Interface Sci 2004;278:96-106
57. Mrak RE, Sheng JG, Griffin WST. Correlation of astrocytic S100A expression with dystrophic neurites in amyloid plaques of Alzheimer's disease. J Neuropathol Exp Neurol 1996;55:273-79
58. Sheng JG, Zhou XQ, Mrak RE, et al. Progressive neuronal injury associated with amyloid plaque formation in Alzheimer disease. J Neuropathol Exp Neurol 1998;57:714-17
59. Thal DR, Capetillo-Zarate E, Schultz C, et al. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner. Acta Neuropathol 2005; 110:459-71
60. Koh J-Y, Yang LL, Cotman CW. A-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res 1990;533:315-20
61. Mattson MP, Cheng B, Davis D, et al. AA peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12;1992:379-89
62. Gray CW, Patel AJ. Neurodegeneration mediated by glutamate and beta-amyloid peptide: A comparison and possible interaction. Brain Res 1995;691:169-79
63. Almeida CG, Tampellini D, Takahashi RH, et al. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol Dis 2005;20:187-98
64. Hsieh H, Boehm J, Sato C, et al. AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 2006;52:831-43
65. Shankar GM, Bloodgood BL, Townsend M, et al. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 2007;27:2866-75
66. Jordan J, Galindo MF, Miller RJ, et al. Isoform-specific effect of apolipoprotein E on cell survival and beta-amyloidYinduced toxicity in rat hippocampal pyramidal neuronal cultures. J Neurosci 1998;18: 195-204
67. Tanzi RE, Wenniger JJ, Hyman BT. Cellular specificity and regional distribution of amyloid beta protein precursor alternative transcripts are unaltered in Alzheimer hippocampal formation. Brain Res Mol Brain Res 1993;18:246-52
68. Stokin GB, Goldstein LS. Axonal transport and Alzheimer's disease. Annu Rev Biochem 2006;75:607-27